Business Wire

TX-MARY-KAY-INC

7.7.2022 16:32:09 CEST | Business Wire | Press release

Share
Mary Kay Inc. Partners With Dr. Jack Gilbert to Further Study Skin’s “Microbiome” and the Impact on the Aging Process

Mary Kay Inc., one of the world’s leading skincare research companies, has announced a new partnership with Dr. Jack Gilbert, professor of pediatrics at the University of California San Diego School of Medicine and professor of microbial oceanography at UC San Diego Scripps Institution of Oceanography. Through the partnership, scientists at Mary Kay will work in conjunction with Dr. Gilbert to study one of the most important—but least understood—areas of aging and skin health: the skin Microbiome.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220707005167/en/

“Understanding how our normal aging process influences microbiota of the skin may provide startling new discoveries that shape the future in designing cosmetic products,” said Dr. Lucy Gildea, Chief Innovation Officer, Product and Science at Mary Kay Inc. “We’re thrilled to be partnering with Dr. Gilbert to better understand the impact of the microbiome in overall skin health.”

In 2022, Dr. Gilbert became co-director of the Microbiome and Metagenomics Center at UC San Diego, part of the National Institutes of Health’s $175 million Nutrition for Precision Health program. Combined with Dr. Gilbert’s expertise, scientists at Mary Kay hope to explore how different skin attributes are associated with microbial shifts in women. “There’s a knowledge gap here,” Dr. Gildea added. “We hope to bridge it.”

Previous research has concluded that human skin has its own complex ecosystem of bacteria and other microorganisms that serve as its healthy foundation. Much like what has been found in the gut, human skin—the body’s largest organ—needs these bacteria for optimal function. These bacterial communities also maintain a unique signature based on location, age, gender, and interaction with the environment. There is very limited knowledge of exactly what factors contribute to the highly variable bacterial communities on the skin and their impact on the aging process.

The partnership with Dr. Gilbert is just the latest effort by Mary Kay to reinforce the brand’s long-standing commitment to advancing skin health research and development. Mary Kay holds more than 1,600 patents for products, technologies, and packaging designs in its global portfolio.

About Mary Kay

One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey to economic independence through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com , find us on Facebook , Instagram , and LinkedIn , or follow us on Twitter .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Boomi Celebrates FY26 Global Partner Award Winners12.5.2026 15:00:00 CEST | Press release

Boomi™, the data activation company, announced today the winners of its FY26 Global Partner Awards, recognized at the 2026 Boomi Partner Summit held in Chicago, Illinois. The awards honor partners that are driving innovation and delivering measurable business outcomes for customers. The winners were selected for their ability to leverage the full breadth of the Boomi Enterprise Platform to manage complexity, activate data, and accelerate agentic transformation. “As organizations advance their adoption of AI, our partners play a critical role in turning strategy into measurable outcomes,” said Dan McAllister, Senior Vice President of Global Alliances and Channels at Boomi. “These award winners are not only advancing innovation but also helping customers activate data, integrate systems, and operationalize AI to unlock new levels of efficiency, agility, and growth.” This year’s winners by category include: Global Partner of the Year: Infosys AMER Partner of the Year: RSM EMEA Partner of

MMS Strengthens Science-Led Global Leadership, Naming Ben Dudley as President12.5.2026 15:00:00 CEST | Press release

MMS Holdings, a global, data-focused clinical research organization (CRO), today named UK-based Ben Dudley as President, extending his existing role as Chief Commercial Officer. The expanded position further supports MMS’ vision and growth as a science-led CRO, helping sponsors worldwide navigate complexity, reduce risk, and advance clinical programs through its integrated biometrics and regulatory capabilities. Dudley’s appointment reinforces MMS’ increasing international presence and builds on strong recent momentum in Europe, including the 2025 acquisition of Exploristics, a Belfast-based biostatistics and data science company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260512803475/en/ Ben Dudley, President and Chief Commercial Officer, MMS As clinical development programs become more complex and globalized, MMS continues to invest in the talent, technology, and organizational structure required to support sponsors w

Energy Vault and Eskom Announce Strategic Development Agreement to Deploy Grid-Scale Gravity Energy Storage Systems in South Africa12.5.2026 15:00:00 CEST | Press release

Eskom and Energy Vault are announcing an agreement to deploy a gravity storage system at the Hendrina Power Station in Mpumalanga province, South Africa, with intention to license, co-develop and partner to deploy up to 4GWh of long duration energy storage across 16 SADC member statesThe partnership will significantly advance regional efforts to transition away from coal, leverage joint material science technology for economic re-use of waste coal ash within the energy storage medium while enabling grid reliability, job creation, and local economic development Energy Vault Holdings, Inc. (NYSE: NRGV) (“Energy Vault” or “the Company”), a global leader in sustainable, grid-scale energy storage and AI compute infrastructure solutions, today announced a strategic development agreement with Eskom Holdings SOC Limited (“Eskom”), South Africa’s state-owned electricity utility, to deploy a long-duration gravity energy storage system (GESS). This press release features multimedia. View the full

Boomi Announces FY26 EMEA Partner Award Winners12.5.2026 15:00:00 CEST | Press release

Boomi™, the data activation company, today announced the winners of its FY26 EMEA Partner Awards. The programme celebrates Boomi partners that are driving innovation and delivering measurable business outcomes for customers across the region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260512152077/en/ Boomi Announces FY26 EMEA Partner Award Winners The awards highlight organizations that are leveraging the full breadth of the Boomi Enterprise Platform to activate data, simplify complexity, and accelerate agentic transformation, enabling customers to innovate faster, address evolving business challenges, and deliver meaningful impact across industries and communities. “Across EMEA, the conversation has fundamentally shifted. Organizations are no longer asking whether to transform, but how fast they can get there. Data activation and agentic transformation have moved from ambition to imperative, and the pressure to turn fr

Medisca and dsm–firmenich Partner to Expand Access to Pharmaceutical-Grade Vitamin APIs for U.S. Compounding Market12.5.2026 15:00:00 CEST | Press release

Medisca, a global leader in personalized pharmaceutical medicine, has entered into a strategic partnership with dsm–firmenich, a leading ingredient manufacturer serving regulated pharmaceutical markets worldwide. Through this partnership, Medisca will make a portfolio of pharmaceutical-grade vitamin active pharmaceutical ingredients (APIs) available to U.S. compounding professionals, expanding access to ingredients manufactured within European cGMP environments and supported by established quality systems and documentation standards. Strengthening the foundation of compounding As compounding continues to support increasingly complex and regulated care settings, expectations around ingredient sourcing, consistency, and documentation continue to rise. Pharmacies and 503B outsourcing facilities are seeking partners that enable them to operate with confidence at scale. This partnership reflects a long-term commitment to expanding access to high-quality ingredient solutions while preserving

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye